Login to Your Account

Financings Roundup

Kala Tops Off Seed Round with Additional $6.2M Equity Deal

By Catherine Shaffer
Staff Writer

Thursday, March 15, 2012
Kala Pharmaceuticals Inc., of Waltham, Mass., raised $6.2 million in equity financing from its existing investors. The new round completes its seed financing of $11.2 million to support its pipeline in diseases affecting mucosal tissues, including cystic fibrosis.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription